QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver
出版年份 2023 全文链接
标题
QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver
作者
关键词
-
出版物
PHYTOMEDICINE
Volume -, Issue -, Pages 155192
出版商
Elsevier BV
发表日期
2023-11-05
DOI
10.1016/j.phymed.2023.155192
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Attenuating lipid metabolism in atherosclerosis: The potential role of Anti-oxidative effects on low-density lipoprotein of herbal medicines
- (2023) Huxinyue Duan et al. Frontiers in Pharmacology
- QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPARγ-LXRα/β-ABCA1 pathway
- (2023) Jing Xie et al. JOURNAL OF ETHNOPHARMACOLOGY
- Free Cholesterol Bioavailability and Atherosclerosis
- (2022) Rei J. Abe et al. Current Atherosclerosis Reports
- Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease
- (2022) Hongliang Xue et al. CIRCULATION RESEARCH
- Establishment and validation of the quantitative analysis of multi‐components by single marker for the quality control of Qishen Yiqi dripping pills by high‐performance liquid chromatography with charged aerosol detection
- (2021) Linlin Wu et al. PHYTOCHEMICAL ANALYSIS
- Canagliflozin Facilitates Reverse Cholesterol Transport Through Activation of AMPK/ABC Transporter Pathway
- (2021) Yingnan Zhao et al. Drug Design Development and Therapy
- Crosstalk Between LXR and Caveolin-1 Signaling Supports Cholesterol Efflux and Anti-Inflammatory Pathways in Macrophages
- (2021) Cristina M. Ramírez et al. Frontiers in Endocrinology
- Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
- (2020) Chainika Khatana et al. Oxidative Medicine and Cellular Longevity
- Full-length transcript sequencing and comparative transcriptomic analysis to evaluate the contribution of osmotic and ionic stress components towards salinity tolerance in the roots of cultivated alfalfa (Medicago sativa L.)
- (2019) Dong Luo et al. BMC PLANT BIOLOGY
- HDL and Reverse Cholesterol Transport
- (2019) Mireille Ouimet et al. CIRCULATION RESEARCH
- Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage
- (2019) Chaoran Ma et al. NEUROLOGY
- A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
- (2019) Pierre Amarenco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polyphenol Effects on Cholesterol Metabolism via Bile Acid Biosynthesis, CYP7A1: A Review
- (2019) Karen F. Chambers et al. Nutrients
- Ginkgo biloba extracts prevent aortic rupture in angiotensin II-infused hypercholesterolemic mice
- (2018) Xiao-fang Huang et al. ACTA PHARMACOLOGICA SINICA
- SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux
- (2018) Wen-Jun Shen et al. Annual Review of Physiology
- Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation
- (2018) Rui Zhan et al. Cell Death & Disease
- (–)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B
- (2018) Wei Wang et al. Frontiers in Pharmacology
- The Contribution of Different Components in QiShenYiQi Pills® to Its Potential to Modulate Energy Metabolism in Protection of Ischemic Myocardial Injury
- (2018) Yuan-Chen Cui et al. Frontiers in Physiology
- SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis
- (2017) MacRae F. Linton et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- QiShenYiQi pill attenuates atherosclerosis by promoting regulatory T cells, inhibiting T helper 17 cells and accelerating cholesterol excretion
- (2017) Li Peng et al. Oncotarget
- TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis
- (2016) Joanne Hsieh et al. NATURE
- QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode
- (2015) Yuan-Yuan Chen et al. Scientific Reports
- A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action
- (2014) Xiang Li et al. PLoS One
- Activation of Liver X Receptor Decreases Atherosclerosis in Ldlr −/− Mice in the Absence of ATP-Binding Cassette Transporters A1 and G1 in Myeloid Cells
- (2013) Mojdeh S. Kappus et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice
- (2013) Arne Dikkers et al. HEPATOLOGY
- Cholesterol Efflux and Atheroprotection
- (2012) Robert S. Rosenson et al. CIRCULATION
- Progress and challenges in translating the biology of atherosclerosis
- (2011) Peter Libby et al. NATURE
- Liver X Receptor Signaling Pathways and Atherosclerosis
- (2010) Anna C. Calkin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Global Chemome Study by LC Coupled with DAD and ESI–Q–TOF MS of a Composite Traditional Chinese Medicine Qishenyiqi Dropping Pills
- (2010) Jing Wang et al. CHROMATOGRAPHIA
- A piRNA Pathway Primed by Individual Transposons Is Linked to De Novo DNA Methylation in Mice
- (2008) Alexei A. Aravin et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started